Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
The most likely diagnosis in a patient with dilated RV and RA presenting with atrial fibrillation is arrhythmogenic right ventricular cardiomyopathy (ARVC), particularly when these findings occur in a younger patient with arrhythmias. 1
Diagnostic Reasoning
The combination of dilated right ventricle, dilated right atrium, and atrial fibrillation forms a characteristic triad strongly suggestive of ARVC. This pattern reflects the progressive structural and electrical remodeling that defines this genetic cardiomyopathy 2.
Key Diagnostic Features Supporting ARVC:
- Right-sided chamber dilation: Both RV and RA dilation are hallmark features, with RA dilation specifically linked to arrhythmic events in ARVC patients 1
- Atrial fibrillation prevalence: AF occurs in approximately 15% of ARVC patients overall, but increases to 30% in advanced disease stages 2
- Histopathologic correlation: The RA in ARVC patients shows similar pathology to the RV—fibrofatty replacement, reduced cardiomyocytes, adipocyte infiltration, and interstitial fibrosis—explaining the high prevalence of atrial arrhythmias 3
Confirming the Diagnosis
Advanced imaging with cardiac MRI is the preferred diagnostic modality to establish ARVC diagnosis, as it can detect:
- RV free wall dyskinesia and aneurysmal outpouching 4
- Late gadolinium enhancement indicating fibrofatty replacement 5
- Subtle biventricular functional abnormalities 1
Critical Diagnostic Algorithm:
- Obtain ECG: Look for inverted T waves in V1-V3, epsilon waves, prolonged QTc, ventricular ectopy from RV origin 5
- Perform echocardiography: Assess RV dilation, reduced TAPSE (<17mm), low fractional area change, tricuspid regurgitation, and RA dilation 1
- Order cardiac MRI: Essential for tissue characterization and detecting fibrofatty replacement 1
- Consider genetic testing: Indicated when imaging shows RV pathology combined with ECG abnormalities or family history 1
Important Differential Considerations
While ARVC is most likely, exclude other causes of RV dilation with AF:
- Pulmonary hypertension: Would show RV hypertrophy more than dilation initially, elevated pulmonary pressures
- Atrial septal defect: Look for left-to-right shunt on echocardiography with bubble study
- Chronic pulmonary embolism: Clinical history and CT pulmonary angiography
- RV endomyocardial fibrosis: Geographic considerations (tropical regions), different imaging pattern 6
Critical Prognostic Implications
AF in ARVC carries serious prognostic significance and demands aggressive management:
- 4-fold increased risk of life-threatening ventricular arrhythmias 2
- 3-fold higher risk of recurrent ventricular tachycardia after ablation 2
- Increased heart failure hospitalization and mortality 2
- Frequent cause of inappropriate ICD shocks 2
Risk Stratification Parameters:
- Severely reduced RV function
- Left ventricular involvement (strong marker for ventricular arrhythmias) 1
- Reduced TAPSE and low fractional area change
- Significant tricuspid regurgitation 1
Management Approach
All patients meeting ARVC diagnostic criteria with AF require:
- ICD evaluation: Continuous assessment for implantation given the 4-fold increased arrhythmic risk with AF 2
- Anticoagulation: Mandatory for stroke prevention
- Medical therapy: Beta-blockers, ACE inhibitors, spironolactone, consider amiodarone for rhythm control 4
- Structured follow-up: Annual echocardiography, CMR every 3-5 years or when clinical status changes 1
- Family screening: First-degree relatives require evaluation starting at age 10 1
Common Pitfalls to Avoid
- Do not dismiss RV dilation as "athlete's heart" when combined with AF and ECG abnormalities—obvious RV dilation with normal ECG is rare in ARVC 1
- Do not delay genetic testing when imaging pathology coexists with ECG markers or arrhythmias 1
- Do not underestimate AF significance—it is not merely a rhythm disturbance but a marker of advanced disease and dramatically increased mortality risk 2
- Do not rely on echocardiography alone—CMR is essential for definitive diagnosis and tissue characterization 1